{"transactions":[{"id":4639311,"issuer":{"id":4678,"kind":"organization","name":"LB PHARMACEUTICALS INC","symbol":"LBRX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Emplopyee Stock Option (Right to Buy)","published_at":"2026-10-13T20:10:08.000Z","date":"2026-10-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on September 2, 2027, and the remaining shares subject to the option award shall vest over the following three years on a monthly basis on the last day of the month commencing on September 30, 2027, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":200000,"derivative":{"exercise_price":37.22,"expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001746372-26-000007","document":"form4-10132026_041004.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1746372/000174637226000007/form4-10132026_041004.xml","form_type":"4"}},{"id":865241,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2026-03-03T21:14:36.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":95700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":95700,"derivative":{"exercise_price":13.97,"expiration_date":"2036-02-27","underlying":"Common Stock","underlying_shares":95700},"source":{"system":"sec-edgar","filing":"0001600620-26-000023","document":"wk-form4_1772572473.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000023/wk-form4_1772572473.xml","form_type":"4"}},{"id":865240,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:14:36.000Z","date":"2026-03-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":37511,"price":14.21,"value":533031.31,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":576421,"source":{"system":"sec-edgar","filing":"0001600620-26-000023","document":"wk-form4_1772572473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000023/wk-form4_1772572473.xml","form_type":"4"}},{"id":865239,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-03T21:14:36.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":57229,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four\nprogressively higher target prices, with respective one year retention periods per tranche achievement."}],"balance_after":613932,"source":{"system":"sec-edgar","filing":"0001600620-26-000023","document":"wk-form4_1772572473.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000023/wk-form4_1772572473.xml","form_type":"4"}},{"id":887486,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-02-23T21:05:56.000Z","date":"2026-02-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":32424,"price":14.4,"value":466905.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of restricted stock units."}],"balance_after":556703,"source":{"system":"sec-edgar","filing":"0001746372-26-000002","document":"wk-form4_1771880754.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000174637226000002/wk-form4_1771880754.xml","form_type":"4"}},{"id":950026,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:11:21.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":40161,"price":15.95,"value":640567.95,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld to satisfy tax withholding obligations upon the vesting of performance awards."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,721 common shares were acquired on May 30, 2025 and 1,168\ncommon shares were acquired on November 28, 2025."}],"balance_after":589127,"source":{"system":"sec-edgar","filing":"0001600620-26-000003","document":"wk-form4_1767647470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000003/wk-form4_1767647470.xml","form_type":"4"}},{"id":950025,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-01-05T21:11:21.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":49038,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares earned upon certification of performance for a performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2025 and December 31, 2026."}],"balance_after":626399,"source":{"system":"sec-edgar","filing":"0001600620-26-000003","document":"wk-form4_1767647470.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062026000003/wk-form4_1767647470.xml","form_type":"4"}},{"id":1226427,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-03-05T01:58:10.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":124393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":124393,"derivative":{"exercise_price":7.55,"expiration_date":"2035-02-28","underlying":"Common Stock","underlying_shares":124393},"source":{"system":"sec-edgar","filing":"0001600620-25-000020","document":"wk-form4_1741139883.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000020/wk-form4_1741139883.xml","form_type":"4"}},{"id":1226426,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:58:10.000Z","date":"2025-03-04","kind":"sale","planned":false,"acquired":false,"shares":56154,"price":7.92,"value":444739.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs related to the March 2, 2022 and March 2, 2023 grants."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.76 to $8.10, inclusive. The reporting person undertakes to provide to the\nIssuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":577361,"source":{"system":"sec-edgar","filing":"0001600620-25-000020","document":"wk-form4_1741139883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000020/wk-form4_1741139883.xml","form_type":"4"}},{"id":1226425,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:58:10.000Z","date":"2025-03-03","kind":"sale","planned":false,"acquired":false,"shares":61859,"price":8,"value":494872.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) related to the February 20, 2024 grant and March 2, 2023 performance award."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.79 to $8.13, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":633515,"source":{"system":"sec-edgar","filing":"0001600620-25-000020","document":"wk-form4_1741139883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000020/wk-form4_1741139883.xml","form_type":"4"}},{"id":1226424,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:58:10.000Z","date":"2025-03-03","kind":"grant","planned":false,"acquired":true,"shares":114711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents grant of performance award payable solely in common shares of the Issuer that vest in two (2) equal annual installments on December 31, 2024 and December 31, 2025."}],"balance_after":695374,"source":{"system":"sec-edgar","filing":"0001600620-25-000020","document":"wk-form4_1741139883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000020/wk-form4_1741139883.xml","form_type":"4"}},{"id":1226423,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2025-03-05T01:58:10.000Z","date":"2025-02-28","kind":"grant","planned":false,"acquired":true,"shares":81457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Each performance right represents a contingent right to receive one common share of the Issuer. The performance rights vest in four tranches upon the Issuer's common shares achieving four progressively higher target prices, with respective one year retention periods per tranche achievement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes common shares acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,630 common shares were acquired on May 31, 2024 and 1,648 common shares were acquired on November 29, 2024."}],"balance_after":580663,"source":{"system":"sec-edgar","filing":"0001600620-25-000020","document":"wk-form4_1741139883.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062025000020/wk-form4_1741139883.xml","form_type":"4"}},{"id":1588561,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-03-07T21:44:49.000Z","date":"2024-03-06","kind":"sale","planned":false,"acquired":false,"shares":34811,"price":5.6,"value":194941.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of Restricted Stock Units related to the March 2, 2022 and March 2, 2023 grants."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price in column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.475 to $5.755, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":495928,"source":{"system":"sec-edgar","filing":"0001600620-24-000037","document":"wk-form4_1709847876.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000037/wk-form4_1709847876.xml","form_type":"4"}},{"id":1624610,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:27:55.000Z","date":"2024-02-20","kind":"grant","planned":false,"acquired":true,"shares":196153,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 1,732 shares of common stock were acquired on May 31, 2023 and 1,742 shares of common stock were acquired on November 30, 2023."}],"balance_after":530739,"source":{"system":"sec-edgar","filing":"0001600620-24-000018","document":"wk-form4_1708637259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000018/wk-form4_1708637259.xml","form_type":"4"}},{"id":1624607,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-02-22T21:17:28.000Z","date":"2023-03-02","kind":"sale","planned":false,"acquired":false,"shares":11398,"price":8.78,"value":100074.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":331112,"source":{"system":"sec-edgar","filing":"0001600620-24-000014","document":"wk-form4a_1708636621.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000160062024000014/wk-form4a_1708636621.xml","form_type":"4/A","original_submission_date":"2023-03-06"}},{"id":1968232,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T21:29:20.000Z","date":"2023-03-02","kind":"sale","acquired":false,"shares":11296,"price":8.94,"value":100986.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents the number of shares automatically sold to cover tax withholding obligations in connection with the vesting of RSUs."}],"balance_after":331214,"source":{"system":"sec-edgar","filing":"0001628280-23-006531","document":"wf-form4_167813814945028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828023006531/wf-form4_167813814945028.xml","form_type":"4"}},{"id":1968231,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T21:29:20.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":229421,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of Restricted Stock Units (RSUs) payable solely in common stock of the Issuer that vest in three (3) equal annual installments on the first, second and third anniversary of the grant date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Includes shares of common stock acquired by the reporting person pursuant to the Issuer's 2021 Employee Share Purchase Plan as follows: 743 shares of common stock were acquired on May 31, 2022 and 1,656 shares of common stock were acquired on November 30, 2022."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"The reporting person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 229,421 newly awarded RSUs, 104,080 RSUs previously reported in Table II, which vests in three (3) equal annual installments beginning March 2, 2022 (Prior RSUs), and 6,610 shares of common stock. On March 2, 2023, 34,693 of Prior RSUs vested and 69,387 of Prior RSUs remained unvested."}],"balance_after":342510,"source":{"system":"sec-edgar","filing":"0001628280-23-006531","document":"wf-form4_167813814945028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828023006531/wf-form4_167813814945028.xml","form_type":"4"}},{"id":2307310,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T22:06:44.000Z","date":"2022-03-31","kind":"grant","acquired":true,"shares":20239,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of the stock option will immediately vest on the date that it is granted."}],"balance_after":20239,"derivative":{"exercise_price":0.7247,"exercise_date":"2022-03-31","expiration_date":"2032-03-31","underlying":"Common Stock","underlying_shares":20239},"source":{"system":"sec-edgar","filing":"0001578563-22-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856322000011/primary_doc.xml","form_type":"4"}},{"id":2349609,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-03-04T21:12:13.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":178063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"One-third of the shares subject to the option vests twelve months from the grant date, and the remainder vests in twenty-four equal monthly installments thereafter."}],"balance_after":178063,"derivative":{"exercise_price":12.01,"expiration_date":"2032-03-02","underlying":"Common Stock","underlying_shares":178063},"source":{"system":"sec-edgar","filing":"0001628280-22-005127","document":"wf-form4_164642831364007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005127/wf-form4_164642831364007.xml","form_type":"4"}},{"id":2349608,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-04T21:12:13.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":104080,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock. The RSUs shall vest in three (3) equal annual installments beginning March 2, 2022, provided the Reporting Person remains continuously employed by the Issuer through each annual vesting date."}],"balance_after":104080,"derivative":{"underlying":"Common Shares","underlying_shares":104080},"source":{"system":"sec-edgar","filing":"0001628280-22-005127","document":"wf-form4_164642831364007.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005127/wf-form4_164642831364007.xml","form_type":"4"}},{"id":2349607,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T21:12:13.000Z","date":"2022-03-02","kind":"sale","acquired":false,"shares":3060,"price":12.01,"value":36750.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares sold to cover tax withholding obligations in connection with the vesting of Performance Awards."}],"balance_after":6610,"source":{"system":"sec-edgar","filing":"0001628280-22-005127","document":"wf-form4_164642831364007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005127/wf-form4_164642831364007.xml","form_type":"4"}},{"id":2349606,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-03-04T21:12:13.000Z","date":"2022-03-02","kind":"grant","acquired":true,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 18, 2021, the Reporting Person was granted stock based performance awards (\"Performance Awards\") which vests when specific performance metrics are met based on the results for the year ended December 31, 2021. It was determined that as of March 2, 2022, the Reporting Person partially met the performance criteria and received shares of common stock for no consideration."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 170 shares acquired by the Reporting Person under the Issuer's 2021 Employee Share Purchase Plan on December 1, 2021."}],"balance_after":9670,"source":{"system":"sec-edgar","filing":"0001628280-22-005127","document":"wf-form4_164642831364007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828022005127/wf-form4_164642831364007.xml","form_type":"4"}},{"id":2447599,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-04T21:25:07.000Z","date":"2021-12-31","kind":"grant","acquired":true,"shares":8920,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":8920,"derivative":{"exercise_price":1.7,"exercise_date":"2021-12-31","expiration_date":"2031-12-31","underlying":"Common Stock","underlying_shares":8920},"source":{"system":"sec-edgar","filing":"0001062993-22-000244","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000106299322000244/form4.xml","form_type":"4"}},{"id":2551319,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-04T20:42:47.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":6939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":6939,"derivative":{"exercise_price":2.18,"exercise_date":"2021-09-30","expiration_date":"2031-09-30","underlying":"Common Stock","underlying_shares":6939},"source":{"system":"sec-edgar","filing":"0001878894-21-000009","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000187889421000009/edgar.xml","form_type":"4"}},{"id":2643712,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-02T20:11:14.000Z","date":"2021-06-30","kind":"grant","acquired":true,"shares":4620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":4620,"derivative":{"exercise_price":3.27,"exercise_date":"2021-06-30","expiration_date":"2031-06-30","underlying":"Common Stock","underlying_shares":4620},"source":{"system":"sec-edgar","filing":"0001192482-21-000603","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248221000603/edgar.xml","form_type":"4"}},{"id":2663000,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:31:57.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option will be fully vested and exercisable on June 15, 2022, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":40000,"derivative":{"exercise_price":3.56,"exercise_date":"2022-06-15","expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001192482-21-000520","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248221000520/edgar.xml","form_type":"4"}},{"id":2718086,"issuer":{"id":4463,"kind":"organization","name":"Aurinia Pharmaceuticals Inc.","symbol":"AUPH"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-05-11T20:53:55.000Z","date":"2021-05-11","kind":"purchase","acquired":true,"shares":1000,"price":9.74,"value":9740.0,"ownership":{"direct":true},"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001628280-21-009835","document":"wf-form4_162076642191509.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1600620/000162828021009835/wf-form4_162076642191509.xml","form_type":"4"}},{"id":2760466,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-02T20:35:38.000Z","date":"2021-03-31","kind":"grant","acquired":true,"shares":5564,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":5564,"derivative":{"exercise_price":3.02,"exercise_date":"2021-03-31","expiration_date":"2031-03-31","underlying":"Common Stock","underlying_shares":5564},"source":{"system":"sec-edgar","filing":"0001653222-21-000002","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000165322221000002/edgar.xml","form_type":"4/A","original_submission_date":"2021-03-31"}},{"id":2919033,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T21:24:36.000Z","date":"2020-12-31","kind":"grant","acquired":true,"shares":5472,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":5472,"derivative":{"exercise_price":2.64,"exercise_date":"2020-12-31","expiration_date":"2030-12-31","underlying":"Common Stock","underlying_shares":5472},"source":{"system":"sec-edgar","filing":"0001192482-21-000038","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248221000038/edgar.xml","form_type":"4"}},{"id":3018164,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T20:37:31.000Z","date":"2020-09-30","kind":"grant","acquired":true,"shares":6374,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":6374,"derivative":{"exercise_price":2.275,"exercise_date":"2020-09-30","expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":6374},"source":{"system":"sec-edgar","filing":"0001192482-20-000755","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248220000755/edgar.xml","form_type":"4"}},{"id":3094879,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-07-01T21:46:01.000Z","date":"2020-06-30","kind":"grant","acquired":true,"shares":4005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"100% of this stock option will immediately vest on the date that it is granted."}],"balance_after":4005,"derivative":{"exercise_price":2.6,"exercise_date":"2020-06-30","expiration_date":"2030-06-30","underlying":"Common Stock","underlying_shares":4005},"source":{"system":"sec-edgar","filing":"0001192482-20-000593","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248220000593/edgar.xml","form_type":"4"}},{"id":3103990,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-19T20:08:38.000Z","date":"2020-06-18","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This stock option will be fully vested and exercisable on June 18, 2021, subject to the Reporting Person's continued service on such vesting date."}],"balance_after":25000,"derivative":{"exercise_price":2.51,"exercise_date":"2021-06-18","expiration_date":"2030-06-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001192482-20-000542","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248220000542/edgar.xml","form_type":"4"}},{"id":3112968,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-12T00:39:07.000Z","date":"2020-06-08","kind":"tax_withholding","acquired":false,"shares":4472,"price":3.22,"value":14399.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock granted July 12, 2018."}],"balance_after":40582,"source":{"system":"sec-edgar","filing":"0001192482-20-000479","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000119248220000479/edgar.xml","form_type":"4"}},{"id":3173744,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-17T20:22:35.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on June 8, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001578563-20-000018","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856320000018/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-07-16"}},{"id":3177708,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-13T22:30:20.000Z","date":"2020-04-09","kind":"grant","acquired":true,"shares":375000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":375000,"derivative":{"exercise_price":2.57,"expiration_date":"2030-04-09","underlying":"Common Stock","underlying_shares":375000},"source":{"system":"sec-edgar","filing":"0001578563-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856320000015/primary_doc.xml","form_type":"4"}},{"id":3177707,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2020-04-13T22:30:20.000Z","date":"2019-06-07","kind":"tax_withholding","acquired":false,"shares":3723,"price":4.85,"value":18056.55,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares forfeited to the Issuer in connection with the satisfaction of tax liabilities incurred upon the vesting of restricted stock granted July 12, 2018."}],"balance_after":45054,"source":{"system":"sec-edgar","filing":"0001578563-20-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856320000015/primary_doc.xml","form_type":"4"}},{"id":3344957,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-12-11T21:41:17.000Z","date":"2019-12-10","kind":"purchase","acquired":true,"shares":2598,"price":2.8475,"value":7397.805,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":48777,"source":{"system":"sec-edgar","filing":"0001578563-19-000039","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000039/primary_doc.xml","form_type":"4"}},{"id":3493767,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2019-06-12T00:47:49.000Z","date":"2019-06-10","kind":"purchase","acquired":true,"shares":1179,"price":2.8475,"value":3357.2025,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan."}],"balance_after":46179,"source":{"system":"sec-edgar","filing":"0001578563-19-000022","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000022/primary_doc.xml","form_type":"4"}},{"id":3567585,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-02T23:16:22.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth of the shares subject to the stock option will vest on the first anniversary of the date of grant, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months."}],"balance_after":175000,"derivative":{"exercise_price":6.22,"expiration_date":"2029-04-01","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001578563-19-000011","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000157856319000011/primary_doc.xml","form_type":"4"}},{"id":3867147,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-07-16T21:12:03.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":105000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options will vest 25% on July 12, 2019, and the remaining 75% of the shares subject to the stock option shall vest in 36 equal monthly installments beginning on August 12, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date."}],"balance_after":105000,"derivative":{"exercise_price":4.5,"exercise_date":"2019-07-12","expiration_date":"2028-07-11","underlying":"Common Stock","underlying_shares":105000},"source":{"system":"sec-edgar","filing":"0001746282-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000174628218000004/primary_doc.xml","form_type":"4"}},{"id":3867146,"issuer":{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX"},"owners":[{"id":63148,"kind":"person","name":"Miller Joseph M","position":1,"cik":"0001746372","reported_name":"Miller Joseph M","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-07-16T21:12:03.000Z","date":"2018-07-12","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in four equal annual installments beginning on July 12, 2019, provided the Reporting Person is then an officer of the Issuer on each such vesting date."}],"balance_after":45000,"source":{"system":"sec-edgar","filing":"0001746282-18-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1534120/000174628218000004/primary_doc.xml","form_type":"4"}}]}